Search by Drug Name or NDC

NDC 53746-0924-05 Lacosamide 100 mg/1 Details

Lacosamide 100 mg/1

Lacosamide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals of New York LLC. The primary component is LACOSAMIDE.

MedlinePlus Drug Summary

Lacosamide is used to control partial onset seizures (seizures that involve only one part of the brain) in adults and children 1 month of age and older. Lacosamide is also used in combination with other medications to control primary generalized tonic-clonic seizures (formerly known as a grand mal seizure; seizure that involves the entire body) in adults and children 4 years of age and older. Lacosamide is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.

Related Packages: 53746-0924-05
Last Updated: 04/21/2024
MedLinePlus Full Drug Details: Lacosamide

Product Information

NDC	53746-0924
Product ID	53746-924_5c54cea8-fde5-41f4-a94b-03b910685b3d
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Lacosamide
Proprietary Name Suffix	n/a
Non-Proprietary Name	Lacosamide
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	100
Active Ingredient Units	mg/1
Substance Name	LACOSAMIDE
Labeler Name	Amneal Pharmaceuticals of New York LLC
Pharmaceutical Class	Decreased Central Nervous System Disorganized Electrical Activity [PE]
DEA Schedule	CV
Marketing Category	ANDA
Application Number	ANDA204857
Listing Certified Through	2024-12-31

Package

NDC 53746-0924-05 (53746092405)

Pricing Information	N/A
NDC Package Code	53746-924-05
Billing NDC	53746092405
Package	500 TABLET in 1 BOTTLE (53746-924-05)
Marketing Start Date	2023-05-17
NDC Exclude Flag	N